FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40539811000001102: Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Mar 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2199001000001116 Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2199021000001111 Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Has AMP Entecavir 500microgram tablets (Fresenius Kabi Ltd) true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Is a Entecavir 500microgram tablets 30 tablet true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Has specific active ingredient Entecavir monohydrate true Inferred relationship Existential restriction modifier
Entecavir 500microgram tablets (Fresenius Kabi Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Entecavir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start